Daniel Carter, 23, said he turned to kratom to break his opioid addiction but instead, it pulled him right back in. Now sober ...

A potentially billion-dollar acquisition of Gilgamesh Pharmaceuticals suggested big pharma may finally be willing to place ...

The Trump administration's cancellation of hundreds of NIH grants left in limbo a project to help people with experimental ...

At a meeting held by the Food and Drug Administration on July 21, 2025, a panel convened by the agency cast doubt on the ...

Just days after the Senate confirmed a new head of the Drug Enforcement Administration (DEA), the agency is promoting yet another message warning against marijuana use, linking it to depression and ...

Four of the most common SSRIs are approved by the FDA for use in kids and teens, and others that are approved for use in adults are commonly prescribed off-label for adolescents. Side effects of these ...

A new review of research on 64 herbal remedies and dietary supplements for depression found ‘substantive’ evidence that only ...

The Food and Drug Administration is considering adding warning labels to antidepressants for women who are pregnant, despite ...

The Food and Drug Administration (FDA) formally requested for a popular kratom derivative to be classified as a ...

A new Genomic Press Interview with Dr. David R. Rubinow explores the transformational effect of his discovery that women with ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...